BioSpace News Archive

Therapeutic cell pioneer Trailhead Biosystems raises Series A funding for development of specialized human cells Financing will expand the company’s High Dimensional Design of Experiments platform (HD-DoE), support the generation of multiple specialized human cells with therapeutic properties and their pilot scale manufacturing

Ozone is a natural gas composed of three atoms of oxygen and is Scientifically Proven to Kill SARS Coronavirus and Influenza; Interest is Sparked in its Ability to Combat COVID-19

JDRF Canada, the leading organization funding type 1 diabetes research, is marking National Diabetes Awareness Month by honouring the power and resilience of the T1D community with the “Dear Type 1” campaign.

Monteris Medical announced today the publication of results from a multicenter clinical study with its NeuroBlate® System for the treatment of drug resistant epilepsy have been published in the peer-reviewed journal Epilepsy Research. The paper describes data from the LAANTERN prospective multicenter registry, sponsored by

Bioventus to Provide CVS Caremark ® with its Portfolio of Preferred Options for Knee Osteoarthritis Patients Seeking Pain Relief

Replica Analytics Ltd., a leading provider of privacy protective synthetic data, is proud to announce that it is providing its data synthesis platform to PHUSE members.

Cerebral Therapeutics, Inc., a clinical-stage pharmaceutical company developing innovative treatments for neurological diseases, has appointed Stephen J. Farr, PhD as Chairman of the board of directors. Dr. Farr is the Co-Founder, President, and Chief Executive Officer of Zogenix, a biopharmaceutical company committed to developing and commercializing therapies with the potential to transform the lives of patients and thei

John Couris is also listed in two Florida magazines tracking the most influential people in the state.

Psilocybin, mescaline, LSD, MDMA, DMT and other psychedelic compounds added to exclusive dealing agreement for the development of psychedelic-based therapeutics

Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), announced that the organization’s Newborn Screening Pilot has been successfully screening babies born in New York State for Duchenne for over a year.